Stay updated on Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior warning about funding/status (Revision: v3.4.1) as administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check23 days agoChange DetectedThe page now includes a government funding status notice and a new revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedThe changes are minor UI and wording updates (Show glossary, capitalization tweaks in QC-related labels, and revision/version indicators) that do not modify study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 entry.SummaryDifference0.0%

- Check65 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure text and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check94 days agoChange DetectedPublications section wording updated to clarify that publications are automatically filled from PubMed and may not be about the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Otelixizumab in New-Onset Type 1 Diabetes Clinical Trial page.